Olmesartan medoxomil (OLM) plus amlodipine (AML) improves BP goal attainment in moderate-to-severe hypertensive patients not adequately controlled with AML monotherapy

被引：0

作者：

Volpe, M. ^{[1
]}

Laeis, P. ^{[2
]}

Ammentorp, B. ^{[2
]}

Haag, U. ^{[3
]}

机构：

[1] Univ Rome, Div Cardiol, Rome, Italy

[2] Daiichi Sankyo Europe GmbH, Munich, Germany

[3] HaaPACS GmbH, Schriesheim, Germany

来源：

JOURNAL OF HYPERTENSION | 2008年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：S473 / S473

页数：1

共 36 条

[21] Efficacy and Safety of Combination Olmesartan Medoxomil (OM) plus Amlodipine Besylate (AML) plus Hydrochlorothiazide (HCTZ) in Patients with Hypertension and Diabetes (The TRINITY Study)
Oparil, Suzanne
John, Thomas Little
Melino, Michael
Fernandez, Victor
Lee, James
Heyrman, Reinilde
DIABETES, 2010, 59 : A183 - A183
[22] CLINICAL AND PATIENT-REPORTED OUTCOMES OF TRIPLE COMBINATION OF OLMESARTAN MEDOXOMIL (OM), AMLODIPINE BESYLATE (AML) AND HYDROCHLOROTHIAZIDE (HCT) IN HYPERTENSIVE PATIENTS
Ehlken, B.
Claus, V
Shlaen, R.
Oberdiek, A. M. S.
VALUE IN HEALTH, 2011, 14 (07) : A385 - A385
[23] EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION ANALYZED BY AGE AND GENDER: THE TRINITY STUDY
Chrysant, S. G.
Melino, M.
Fernandez, V.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2010, 28 : E103 - E103
[24] EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN BLACK AND NON-BLACK PATIENTS: THE TRINITY STUDY
Oparil, S.
Littlejohn, T.
Melino, M.
Fernandez, V.
Lee, J.
Heyrman, R.
ETHNICITY & DISEASE, 2010, 20 (04) : S39 - S39
[25] Efficacy of the combination of amlodipine besylate plus olmesartan medoxomil compared to monotherapy in controlling blood pressure in patients with mild-to-severe hypertension
Chrysant, S. G.
Oparil, S.
Bakris, G.
Melino, M.
Karki, S.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2008, 26 : S375 - S375
[26] Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after MonotherapyA Randomized, Double-Blind, Parallel-Group, Multicentre Study
Vivencio Barrios
Peter Brommer
Uwe Haag
Alberto Calderón
Carlos Escobar
Clinical Drug Investigation, 2009, 29 : 427 - 439
[27] Blood pressure (BP)-lowering efficacy of olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) vs benazepril (BN) plus amlodipine (AML) therapy in black patients (pts) with stage 2 hypertension (HT)
Neutel, J.
Punzi, H.
Xu, J.
Lipka, L.
Chavanu, K.
Dubiel, R.
JOURNAL OF HYPERTENSION, 2008, 26 : S455 - S455
[28] Combination of amlodipine plus olmesartan medoxomil (OM) is effective and safe with long term dosing while treating patients (pts) to blood pressure (BP) goal
Chrysant, S. G.
Oparil, S.
Bakris, G.
Melino, M.
Karki, S.
Lee, J.
Heyrman, R.
JOURNAL OF HYPERTENSION, 2008, 26 : S374 - S374
[29] Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy A Randomized, Double-Blind, Parallel-Group, Multicentre Study
Volpe, Massimo
Brommer, Peter
Haag, Uwe
Miele, Cristina
CLINICAL DRUG INVESTIGATION, 2009, 29 (01) : 11 - 25
[30] Olmesartan medoxomil (OLM) reduces blood pressure (BP) load and improves goal rates more effectively than losartan potassium (LOS) and valsartan (VAL) in patients with essential hypertension
Neutel, J
Lee, Y
Silfani, T
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 70A - 70A

← 1 2 3 4 →